Erythropoietin-Alpha Dosage Requirements in a Provincial Hemodialysis Population: Effect of Switching from Subcutaneous to Intravenous Administration

Colette B. Raymond,David M. Collins,Keevin Bernstein,Dan E. Skwarchuk,Lavern M. Vercaigne

Erythropoietin-Alpha Dosage Requirements in a Provincial Hemodialysis Population: Effect of Switching from Subcutaneous to Intravenous Administration

2005

Colette B. Raymond
David M. Collins
Keevin Bernstein
Dan E. Skwarchuk
Lavern M. Vercaigne

Background: The purpose of this initiative was to compare erythropoietin-α doses in hemodialysis patients who changed from subcutaneous to intravenous administration. The Manitoba R

Keywords:

Erythropoietin
Medicine
Diabetes mellitus
Intensive care medicine
Transferrin saturation
Alpha (ethology)
Population
Hemodialysis
Pure red cell aplasia
Nephrology
Internal medicine
population effect

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations